Loading...

Marc Riedl

TitleClinical Professor
InstitutionUniversity of California San Diego
DepartmentMedicine
Address9500 Gilman Drive #0876
La Jolla CA 92093
Phone858-657-5350
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UCLAClinical Immunology & Allergy Fellowship
    UCLA David Geffen School of Medicine, Los Angeles, CAMSClinical Research
    University of Chicago - Pritzker School of MedicineMD

    Collapse Overview 
    Collapse Overview
    Dr. Riedl is Clinical Director of the US HAEA Angiodema Center at the UC San Diego. His professional focus is on angiodema conditions and primary immunodeficiency, and clinical pharmacology.


    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Banerji A, Li Y, Busse P, Riedl M, Holtzman NS, Li HH, Davis-Lorton M, Bernstein JA, Frank M, Castaldo AJ, Long J, Zuraw B, Lumry W, Christiansen S. Hereditary angioedema from the patient's perspective: A follow-up patient survey. Allergy Asthma Proc. 2018 May 01; 39(3):212-223. PMID: 29669666.
      View in: PubMed
    2. Riedl M, Aygören-Pürsün E, Baker J, Farkas H, Anderson J, Bernstein JA, Bouillet L, Busse P, Manning M, Magerl M, Gompels M, Huissoon AP, Longhurst H, Lumry W, Ritchie B, Shapiro R, Soteres D, Banerji A, Cancian M, Johnston DT, Craig TJ, Launay D, Li HH, Liebhaber M, Nickel T, Offenberger J, Rae W, Schrijvers R, Triggiani M, Wedner HJ, Dobo S, Cornpropst M, Clemons D, Fang L, Collis P, Sheridan WP, Maurer M. Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: the OPUS-2 study. Allergy. 2018 Apr 24. PMID: 29688579.
      View in: PubMed
    3. Riedl M, Relan A, Harper JR, Cicardi M. C1 esterase inhibitor concentrates and attenuated androgens - Authors' reply. Lancet. 2018 Apr 07; 391(10128):1356. PMID: 29636270.
      View in: PubMed
    4. Lumry WR, Craig T, Zuraw B, Longhurst H, Baker J, Li HH, Bernstein JA, Anderson J, Riedl M, Manning ME, Keith PK, Levy DS, Caballero T, Banerji A, Gower RG, Farkas H, Lawo JP, Pragst I, Machnig T, Watson DJ. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. J Allergy Clin Immunol Pract. 2018 Jan 31. PMID: 29391286.
      View in: PubMed
    5. Riedl M, Bernstein JA, Craig T, Banerji A, Magerl M, Cicardi M, Longhurst HJ, Shennak MM, Yang WH, Schranz J, Baptista J, Busse PJ. An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension. Clin Transl Allergy. 2017; 7:36. PMID: 29043014.
      View in: PubMed
    6. Boland BS, Riedl M, Valasek MA, Crowe SE, Sandborn WJ. Vedolizumab in Patients With Common Variable Immune Deficiency and Gut Inflammation. Am J Gastroenterol. 2017 Oct; 112(10):1621. PMID: 28978958.
      View in: PubMed
    7. Riedl M, Li HH, Cicardi M, Harper JR, Relan A. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement. Allergy Asthma Proc. 2017 Nov 13; 38(6):462-466. PMID: 28903805.
      View in: PubMed
    8. Chen M, Riedl M. Emerging Therapies in Hereditary Angioedema. Immunol Allergy Clin North Am. 2017 08; 37(3):585-595. PMID: 28687111.
      View in: PubMed
    9. Riedl M. Angioedema: Challenges and Insights. Immunol Allergy Clin North Am. 2017 08; 37(3):xv-xvi. PMID: 28687115.
      View in: PubMed
    10. Riedl M, Grivcheva-Panovska V, Moldovan D, Baker J, Yang WH, Giannetti BM, Reshef A, Andrejevic S, Lockey RF, Hakl R, Kivity S, Harper JR, Relan A, Cicardi M. Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial. Lancet. 2017 Sep 30; 390(10102):1595-1602. PMID: 28754491.
      View in: PubMed
    11. Geng B, Eastman JJ, Mori K, Braskett M, Riedl M. Utility of minor determinants for skin testing in inpatient penicillin allergy evaluation. Ann Allergy Asthma Immunol. 2017 09; 119(3):258-261. PMID: 28743423.
      View in: PubMed
    12. Riedl M, Banerji A, Busse PJ, Johnston DT, Davis-Lorton MA, Patel S, Parr H, Chiao J, Watson DJ, Burrell E, Machnig T. Patient satisfaction and experience with intravenously administered C1-inhibitor concentrates in the United States. Ann Allergy Asthma Immunol. 2017 07; 119(1):59-64. PMID: 28668241.
      View in: PubMed
    13. Longhurst H, Cicardi M, Craig T, Bork K, Grattan C, Baker J, Li HH, Reshef A, Bonner J, Bernstein JA, Anderson J, Lumry WR, Farkas H, Katelaris CH, Sussman GL, Jacobs J, Riedl M, Manning ME, Hebert J, Keith PK, Kivity S, Neri S, Levy DS, Baeza ML, Nathan R, Schwartz LB, Caballero T, Yang W, Crisan I, Hernandez MD, Hussain I, Tarzi M, Ritchie B, Králícková P, Guilarte M, Rehman SM, Banerji A, Gower RG, Bensen-Kennedy D, Edelman J, Feuersenger H, Lawo JP, Machnig T, Pawaskar D, Pragst I, Zuraw BL. Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor. N Engl J Med. 2017 03 23; 376(12):1131-1140. PMID: 28328347.
      View in: PubMed
    14. Busse P, Baker J, Martinez-Saguer I, Bernstein JA, Craig T, Magerl M, Riedl M, Shapiro R, Frank M, Lumry W, Rosch J, Edelman J, Williams-Herman D, Feuersenger H, Rojavin M. Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1142-1145. PMID: 28286153.
      View in: PubMed
    15. Bernstein JA, Relan A, Harper JR, Riedl M. Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks. Ann Allergy Asthma Immunol. 2017 04; 118(4):452-455. PMID: 28284978.
      View in: PubMed
    16. Craig T, Shapiro R, Vegh A, Baker JW, Bernstein JA, Busse P, Magerl M, Martinez-Saguer I, Riedl M, Lumry W, Williams-Herman D, Edelman J, Feuersenger H, Machnig T, Rojavin M. Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema. Allergy Rhinol (Providence). 2017 Mar 01; 8(1):13-19. PMID: 28381322.
      View in: PubMed
    17. Banerji A, Busse P, Shennak M, Lumry W, Davis-Lorton M, Wedner HJ, Jacobs J, Baker J, Bernstein JA, Lockey R, Li HH, Craig T, Cicardi M, Riedl M, Al-Ghazawi A, Soo C, Iarrobino R, Sexton DJ, TenHoor C, Kenniston JA, Faucette R, Still JG, Kushner H, Mensah R, Stevens C, Biedenkapp JC, Chyung Y, Adelman B. Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis. N Engl J Med. 2017 02 23; 376(8):717-728. PMID: 28225674.
      View in: PubMed
    18. Baker JW, Reshef A, Moldovan D, Harper JR, Relan A, Riedl M. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1091-1097. PMID: 28202404.
      View in: PubMed
    19. Magerl M, Frank M, Lumry W, Bernstein J, Busse P, Craig T, Martinez-Saguer I, Riedl M, Shapiro R, Edelman J, Williams-Herman D, Wood DN, Feuersenger H, Rojavin M. Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registry. Ann Allergy Asthma Immunol. 2017 01; 118(1):110-112. PMID: 27865714.
      View in: PubMed
    20. Otani IM, Lumry WR, Hurwitz S, Li HH, Craig TJ, Holtzman NS, Iandoli MI, Tucker J, Riedl M, Zuraw BL, Banerji A. Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility. J Allergy Clin Immunol Pract. 2017 Mar - Apr; 5(2):442-447.e1. PMID: 27818136.
      View in: PubMed
    21. Riedl M, Lumry WR, Li HH, Banerji A, Bernstein JA, Ba M, Bjrkander J, Magerl M, Maurer M, Rockich K, Chen H, Schranz J. Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema. Allergy Asthma Proc. 2016 Nov; 37(6):489-500. PMID: 27931305.
      View in: PubMed
    22. Frank MM, Zuraw B, Banerji A, Bernstein JA, Craig T, Busse P, Christiansen S, Davis-Lorton M, Li HH, Lumry WR, Riedl M. Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency. Pediatrics. 2016 Nov; 138(5). PMID: 27940765.
      View in: PubMed
    23. Otani IM, Christiansen SC, Busse P, Camargo CA, Zuraw BL, Riedl M, Banerji A. Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):128-134.e4. PMID: 27665386.
      View in: PubMed
    24. Riedl M, Bygum A, Lumry W, Magerl M, Bernstein JA, Busse P, Craig T, Frank MM, Edelman J, Williams-Herman D, Feuersenger H, Rojavin M. Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data. J Allergy Clin Immunol Pract. 2016 Sep-Oct; 4(5):963-71. PMID: 27286778.
      View in: PubMed
    25. Doshi A, Tse K, Riedl M, Zuraw B, Christiansen S. Cases of acquired C1 inhibitor deficiency treated with rituximab. J Allergy Clin Immunol Pract. 2016 Sep-Oct; 4(5):987-8. PMID: 27130715.
      View in: PubMed
    26. Banerji A, Riedl M. Managing the female patient with hereditary angioedema. Womens Health (Lond). 2016 06; 12(3):351-61. PMID: 26978558.
      View in: PubMed
    27. Lumry WR, Farkas H, Moldovan D, Toubi E, Baptista J, Craig T, Riedl M. Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3. Int Arch Allergy Immunol. 2015; 168(1):44-55. PMID: 26556097.
      View in: PubMed
    28. Riedl M. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema. Clin Drug Investig. 2015 Jul; 35(7):407-17. PMID: 26091744; PMCID: PMC4488495.
      View in: PubMed, PubMed Central
    29. Geng B, Thakor A, Clayton E, Finkas L, Riedl M. Factors associated with negative histamine control for penicillin allergy skin testing in the inpatient setting. Ann Allergy Asthma Immunol. 2015 Jul; 115(1):33-8. PMID: 25959032.
      View in: PubMed
    30. Banerji A, Busse P, Christiansen SC, Li H, Lumry W, Davis-Lorton M, Bernstein JA, Frank M, Castaldo A, Long JF, Zuraw BL, Riedl M. Current state of hereditary angioedema management: a patient survey. Allergy Asthma Proc. 2015 May-Jun; 36(3):213-7. PMID: 25976438; PMCID: PMC4405601.
      View in: PubMed, PubMed Central
    31. Riedl M, Lumry WR, Busse P, Levy H, Steele T, Dayno J, Li HH. Prevalence of hereditary angioedema in untested first-degree blood relatives of known subjects with hereditary angioedema. Allergy Asthma Proc. 2015 May-Jun; 36(3):206-12. PMID: 25803135; PMCID: PMC4405600.
      View in: PubMed, PubMed Central
    32. Christiansen SC, Bygum A, Banerji A, Busse P, Li H, Lumry W, Davis-Lorton M, Bernstein JA, Frank MM, Castaldo A, Long JF, Riedl M, Zuraw BL. Before and after, the impact of available on-demand treatment for HAE. Allergy Asthma Proc. 2015 Mar-Apr; 36(2):145-50. PMID: 25715243.
      View in: PubMed
    33. Riedl M. Critical appraisal of androgen use in hereditary angioedema: a systematic review. Ann Allergy Asthma Immunol. 2015 Apr; 114(4):281-288.e7. PMID: 25707325.
      View in: PubMed
    34. Li HH, Moldovan D, Bernstein JA, Reshef A, Porebski G, Stobiecki M, Baker J, Levy R, Relan A, Riedl M. Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks. J Allergy Clin Immunol Pract. 2015 May-Jun; 3(3):417-23. PMID: 25680925.
      View in: PubMed
    35. Bernstein JA, Riedl M, Zacek L, Shapiro RS. Facilitating home-based treatment of hereditary angioedema. Allergy Asthma Proc. 2015 Mar-Apr; 36(2):92-9. PMID: 25551795.
      View in: PubMed
    36. Riedl M, Banerji A, Gower R. Current medical management of hereditary angioedema: follow-up survey of US physicians. J Allergy Clin Immunol Pract. 2015 Mar-Apr; 3(2):220-7. PMID: 25609328.
      View in: PubMed
    37. Craig TJ, Li HH, Riedl M, Bernstein JA, Lumry WR, MacGinnitie AJ, Stolz LE, Biedenkapp J, Chyung Y. Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks. J Allergy Clin Immunol Pract. 2015 Mar-Apr; 3(2):206-212.e4. PMID: 25609335.
      View in: PubMed
    38. Li HH, Busse P, Lumry WR, Frazer-Abel A, Levy H, Steele T, Dayno J, Riedl M. Comparison of chromogenic and ELISA functional C1 inhibitor tests in diagnosing hereditary angioedema. J Allergy Clin Immunol Pract. 2015 Mar-Apr; 3(2):200-5. PMID: 25609336.
      View in: PubMed
    39. Riedl M. The therapeutic landscape for hereditary angioedema: more change on the horizon? Ann Allergy Asthma Immunol. 2014 Oct; 113(4):337-8. PMID: 25256026.
      View in: PubMed
    40. Moellman JJ, Bernstein JA, Lindsell C, Banerji A, Busse PJ, Camargo CA, Collins SP, Craig TJ, Lumry WR, Nowak R, Pines JM, Raja AS, Riedl M, Ward MJ, Zuraw BL, Diercks D, Hiestand B, Campbell RL, Schneider S, Sinert R. A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med. 2014 Apr; 21(4):469-84. PMID: 24730413; PMCID: PMC4100605.
      View in: PubMed, PubMed Central
    41. Riedl M. Reply: To PMID 24565612. J Allergy Clin Immunol Pract. 2014 Mar-Apr; 2(2):239-40. PMID: 24607059.
      View in: PubMed
    42. Riedl M, Bernstein JA, Li H, Reshef A, Lumry W, Moldovan D, Farkas H, Levy R, Baker J, Hardiman Y, Totoritis MC, Relan A, Cicardi M. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. Ann Allergy Asthma Immunol. 2014 Feb; 112(2):163-169.e1. PMID: 24468257.
      View in: PubMed
    43. Riedl M, Lumry WR, Li HH, Craig TJ, Fitts D, Kalfus I, Uknis ME. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema. Am J Rhinol Allergy. 2013 Nov-Dec; 27(6):517-21. PMID: 24274230.
      View in: PubMed
    44. Zuraw BL, Banerji A, Bernstein JA, Busse PJ, Christiansen SC, Davis-Lorton M, Frank MM, Li HH, Lumry WR, Riedl M. US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency. J Allergy Clin Immunol Pract. 2013 Sep-Oct; 1(5):458-67. PMID: 24565617.
      View in: PubMed
    45. Riedl M. Creating a comprehensive treatment plan for hereditary angioedema. Immunol Allergy Clin North Am. 2013 Nov; 33(4):471-85. PMID: 24176212.
      View in: PubMed
    46. Riedl M. Hereditary angioedema with normal C1-INH (HAE type III). J Allergy Clin Immunol Pract. 2013 Sep-Oct; 1(5):427-32. PMID: 24565612.
      View in: PubMed
    47. Riedl M, Levy RJ, Suez D, Lockey RF, Baker JW, Relan A, Zuraw BL. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. Ann Allergy Asthma Immunol. 2013 Apr; 110(4):295-9. PMID: 23535096.
      View in: PubMed
    48. Baker JW, Craig TJ, Riedl M, Banerji A, Fitts D, Kalfus IN, Uknis ME. Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women. Allergy Asthma Proc. 2013 Mar-Apr; 34(2):162-9. PMID: 23484892.
      View in: PubMed
    49. Lumry WR, Bernstein JA, Li HH, MacGinnitie AJ, Riedl M, Soteres DF, Craig TJ, Campion M, Iarrobino R, Stolz LE, Pullman WE. Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation study. Allergy Asthma Proc. 2013 Mar-Apr; 34(2):155-61. PMID: 23484891.
      View in: PubMed
    50. Li HH, Campion M, Craig TJ, Soteres DF, Riedl M, Lumry WR, MacGinnitie AJ, Shea EP, Bernstein JA. Analysis of hereditary angioedema attacks requiring a second dose of ecallantide. Ann Allergy Asthma Immunol. 2013 Mar; 110(3):168-72. PMID: 23548526.
      View in: PubMed
    51. Geng B, Riedl M. HAE update: special considerations in the female patient with hereditary angioedema. Allergy Asthma Proc. 2013 Jan-Feb; 34(1):13-8. PMID: 23406930.
      View in: PubMed
    52. Zuraw BL, Bork K, Binkley KE, Banerji A, Christiansen SC, Castaldo A, Kaplan A, Riedl M, Kirkpatrick C, Magerl M, Drouet C, Cicardi M. Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc. 2012 Nov-Dec; 33 Suppl 1:S145-56. PMID: 23394603.
      View in: PubMed
    53. Kalfus IN, Gower RG, Riedl M, Bernstein JA, Lumry WR, Frank MM. Hereditary angioedema: implications of treating a rare disease. Ann Allergy Asthma Immunol. 2012 Aug; 109(2):150-1; author reply 151. PMID: 22840260.
      View in: PubMed
    54. Riedl M. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus. Clin Ther. 2012 Mar; 34(3):623-30. PMID: 22386830.
      View in: PubMed
    55. Riedl M, Hurewitz DS, Levy R, Busse PJ, Fitts D, Kalfus I. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial. Ann Allergy Asthma Immunol. 2012 Jan; 108(1):49-53. PMID: 22192966.
      View in: PubMed
    56. Lumry WR, Li HH, Levy RJ, Potter PC, Farkas H, Moldovan D, Riedl M, Li H, Craig T, Bloom BJ, Reshef A. Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Ann Allergy Asthma Immunol. 2011 Dec; 107(6):529-37. PMID: 22123383.
      View in: PubMed
    57. Parikh N, Riedl M. New therapeutics in C1INH deficiency: a review of recent studies and advances. Curr Allergy Asthma Rep. 2011 Aug; 11(4):300-8. PMID: 21607669.
      View in: PubMed
    58. Riedl M, Gower RG, Chrvala CA. Current medical management of hereditary angioedema: results from a large survey of US physicians. Ann Allergy Asthma Immunol. 2011 Apr; 106(4):316-322.e4. PMID: 21457880.
      View in: PubMed
    59. Riedl M. Update on the acute treatment of hereditary angioedema. Allergy Asthma Proc. 2011 Jan-Feb; 32(1):11-6. PMID: 21262093.
      View in: PubMed
    60. Riedl M, Campion M, Horn PT, Pullman WE. Response time for ecallantide treatment of acute hereditary angioedema attacks. Ann Allergy Asthma Immunol. 2010 Dec; 105(6):430-436.e2. PMID: 21130380.
      View in: PubMed
    61. Zuraw BL, Frank MM, Riedl M. Introduction: New Perspectives in Hereditary Angioedema (HAE): Molecular Mechanisms & Therapeutic Choices: A CME Symposium Presented at the 2009 World Allergy Congress, Buenos Aires, Argentina, December 9, 2009. World Allergy Organ J. 2010 Sep; 3(9 Suppl):S24. PMID: 23282865; PMCID: PMC3666148.
      View in: PubMed, PubMed Central
    62. Riedl M. Hereditary angioedema therapy: kallikrein inhibition and bradykinin receptor antagonism. World Allergy Organ J. 2010 Sep; 3(9 Suppl):S34-8. PMID: 23282868; PMCID: PMC3666151.
      View in: PubMed, PubMed Central
    63. Cicardi M, Banerji A, Bracho F, Malbrán A, Rosenkranz B, Riedl M, Bork K, Lumry W, Aberer W, Bier H, Bas M, Greve J, Hoffmann TK, Farkas H, Reshef A, Ritchie B, Yang W, Grabbe J, Kivity S, Kreuz W, Levy RJ, Luger T, Obtulowicz K, Schmid-Grendelmeier P, Bull C, Sitkauskiene B, Smith WB, Toubi E, Werner S, Anné S, Björkander J, Bouillet L, Cillari E, Hurewitz D, Jacobson KW, Katelaris CH, Maurer M, Merk H, Bernstein JA, Feighery C, Floccard B, Gleich G, Hébert J, Kaatz M, Keith P, Kirkpatrick CH, Langton D, Martin L, Pichler C, Resnick D, Wombolt D, Fernández Romero DS, Zanichelli A, Arcoleo F, Knolle J, Kravec I, Dong L, Zimmermann J, Rosen K, Fan WT. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med. 2010 Aug 05; 363(6):532-41. PMID: 20818888; PMCID: PMC4662377.
      View in: PubMed, PubMed Central
    64. Lin E, Saxon A, Riedl M. Penicillin allergy: value of including amoxicillin as a determinant in penicillin skin testing. Int Arch Allergy Immunol. 2010; 152(4):313-8. PMID: 20185923.
      View in: PubMed
    65. Craig T, Riedl M, Dykewicz MS, Gower RG, Baker J, Edelman FJ, Hurewitz D, Jacobs J, Kalfus I. When is prophylaxis for hereditary angioedema necessary? Ann Allergy Asthma Immunol. 2009 May; 102(5):366-72. PMID: 19492656.
      View in: PubMed
    66. Riedl M, Saxon A, Diaz-Sanchez D. Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway. Clin Immunol. 2009 Mar; 130(3):244-51. PMID: 19028145; PMCID: PMC2668525.
      View in: PubMed, PubMed Central
    67. Riedl M. The effect of air pollution on asthma and allergy. Curr Allergy Asthma Rep. 2008 Apr; 8(2):139-46. PMID: 18417056.
      View in: PubMed
    68. Riedl M, Nel AE. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr Opin Allergy Clin Immunol. 2008 Feb; 8(1):49-56. PMID: 18188018.
      View in: PubMed
    69. Riedl M, Landaw EM, Saxon A, Diaz-Sanchez D. Initial high-dose nasal allergen exposure prevents allergic sensitization to a neoantigen. J Immunol. 2005 Jun 01; 174(11):7440-5. PMID: 15905593.
      View in: PubMed
    70. Riedl M, Diaz-Sanchez D. Biology of diesel exhaust effects on respiratory function. J Allergy Clin Immunol. 2005 Feb; 115(2):221-8; quiz 229. PMID: 15696072.
      View in: PubMed
    71. Riedl M, Casillas AM. Adverse drug reactions: types and treatment options. Am Fam Physician. 2003 Nov 01; 68(9):1781-90. PMID: 14620598.
      View in: PubMed
    Marc's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (222) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (16) people
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    ↑